CIAM
AVXL icon

Caitong International Asset Management’s Anavex Life Sciences AVXL Stock Holding History

Caitong International Asset Management’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.32K Sell
3,212
-1,631
-34% -$4.83K ﹤0.01% 1201
2026
Q1 		$14.9K Buy
+4,843
New +$21K ﹤0.01% 1034
2025
Q2 		– Sell
-297
Closed -$2.55K – 1999
2025
Q1 		$2.55K Sell
297
-810
-73% -$7.65K ﹤0.01% 1251
2024
Q4 		$11.9K Buy
+1,107
New +$8.52K 0.01% 920

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Caitong International Asset Management's AVXL Position: Q2 2026 in Review

Caitong International Asset Management reduced its Anavex Life Sciences (AVXL) stake by 34% in Q2 2026, selling an estimated $4.83K and leaving 3,212 shares worth $8.32K. The position accounts for ﹤0.01% of the portfolio, ranked #1201.

Caitong International Asset Management first reported a position in AVXL in Q4 2024 and has held it in 4 quarters since. The position peaked at $14.9K in Q1 2026. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Caitong International Asset Management held 3,212 shares of Anavex Life Sciences worth $8.32K as of Q2 2026.
  • Caitong International Asset Management sold 1,631 Anavex Life Sciences shares in Q2 2026, an estimated $4.83K.
  • Anavex Life Sciences made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1201 holding.
  • Caitong International Asset Management first reported a position in Anavex Life Sciences in Q4 2024 and has held it in 4 quarters since.
  • Caitong International Asset Management's Anavex Life Sciences position peaked at $14.9K in Q1 2026.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.